STEER was a retrospective, observational real-world study, evaluating the efficacy of semaglutide 2.4 mg versus tirzepatide for the prevention of MACE in US adults with overweight or obesity and established CVD with no prior history of diabetes, with a primary outcome measure of revised 5-point MACE (heart attack, stroke, hospitalisation for heart failure, coronary revascularisation, and death from any cause) and revised 3-point MACE (heart attack, stroke and death from any cause)
Aip regulates cAMP signalling and GH secretion in GH3 cells
La empresa espera que la pastilla de Wegovy est ampliamente disponible en enero, segn un portavoz de Novo Nordisk
However, a good rule of thumb is that losing weight generally leads to lower blood pressure
TRIUMPH-7 studies retatrutide in adults with obesity and chronic low back pain